NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 19 March 2010 In a recent Science Advisory, the American Heart Association and the American College of Cardiology Foundation have summarised the currently available data on the cardiovascular risks […]
Category Archives: Diabetes
NPC Archive Item: Statins and risk of diabetes
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 01 March 2010 This meta-analysis found statin therapy was associated with a small increase in the absolute risk of developing diabetes. However, for people in whom statin therapy is […]
NPC Archive Item: Severe hypoglycaemia with intensive glucose-lowering therapy in type 2 diabetes: risk factors and mortality
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 8 February 2010 An epidemiological analysis [1] of data from the ACCORD study identified an association between symptomatic hypoglycaemia and mortality. However, this did not explain the increased mortality […]
NPC Archive Item: Blood glucose lowering and mortality in type 2 diabetes: not too little, not too much
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 8 February 2010 A large retrospective cohort study of patients with type 2 diabetes receiving intensive glucose control treatment suggests that the risk of all-cause mortality increases above and […]
NPC Archive Item: More data suggest aspirin is ineffective for primary prevention in patients with diabetes
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 25 January 2010 This meta-analysis found aspirin did not statistically significantly reduce the risk of major CV events, CV mortality or all-cause mortality in people with diabetes and no […]
NPC Archive Item: Lower HbA1c associated with increased risk of car crashes in people with diabetes
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 22 January 2010 A Canadian case-control study has found an association between low HbA1c and risk of car crashes in people with diabetes. They found a relative increase in […]
NPC Archive Item: Observational study of hypoglycaemic drugs has limitations
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 15th January 2010 Compared with metformin monotherapy, the fully adjusted analysis in this UK cohort study found no increased risk of heart failure or myocardial infarction with pioglitazone▼ or […]
NPC Archive Item: Study of insulin detemir should not deflect from NICE guidance
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 30 November 2009 This open label randomised trial suggests that using insulin detemir in people with type 2 diabetes leads to similar median HbA1c levels as twice daily biphasic […]
NPC Archive Item: Intensive blood glucose control in type 1 diabetes reduces complications long-term
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 2nd September 2009 Observational follow-up of two cohorts of people with type 1 diabetes over 30 years has found that the cumulative incidences of some serious complications are lower […]
NPC Archive Item: More on glitazone safety: how do pioglitazone▼ and rosiglitazone compare?
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 2nd September 2009 Two recently published Canadian cohort studies have assessed cardiovascular safety and fracture risk with pioglitazone▼ and rosiglitazone. The BMJ study found pioglitazone▼ was associated with a […]